Johnson & Johnson Beats Procter & Gamble for Long-Term Dividend Investors
Choosing between Johnson & Johnson (NYSE:JNJ) and Procter & Gamble (NYSE:PG) for a 20-year investment horizon highlights key differences in dividend coverage, business durability, and structural risks. Both companies trade at 21x forward earnings, making valuation a non-factor. However, J&J's 46% payout ratio compared to P&G's 62% suggests stronger long-term dividend sustainability.
P&G boasts a longer dividend track record, with 70 consecutive years of increases versus J&J's 64. P&G also offers a higher yield at 2.98% compared to J&J's 2.12%. Yet, J&J's dividend consumes less of its earnings, leaving more room for future increases. J&J expects free cash flow to approach $21 billion in 2026, while P&G plans to pay out over $10 billion in dividends in fiscal 2027.
P&G excels in business durability, with steady demand for its consumer products like Tide and Pampers. J&J, however, faces legal and structural risks, including litigation charges and competition for its Stelara drug. Despite these challenges, J&J's share price has risen 180.5% over ten years, nearly double P&G's 116.7% gain. Management targets double-digit earnings growth by decade's end, further strengthening its dividend profile.
The verdict favors J&J for long-term investors, thanks to its stronger dividend coverage and growth prospects. P&G remains a solid choice for retirees seeking higher current yields and a proven payment record. However, J&J's lower payout ratio and growth potential make it the better pick for a 20-year investment.